Jan Kaiserle

Jan Kaiserle

Medical Systems Advisor
Jan Kaiserle specializes in medical research and evidence-based medicine. He explores the latest advancements in medical science, clinical trials, and healthcare technologies to improve diagnosis, treatment, and disease prevention. His content bridges the gap between clinical research and practice, providing meaningful insights for healthcare professionals.
Are Trump's Public Health Cuts Threatening State Emergencies?
Regulatory & Compliance Are Trump's Public Health Cuts Threatening State Emergencies?

The recent lawsuit initiated by a coalition of 23 states and Washington, D.C., against the U.S. Department of Health and Human Services (HHS) is raising critical concerns about the potential impact of over $11 billion cuts to public health funding. These cuts, originally allocated during the

HHS Undergoes Massive Restructuring, Slashing 10,000 Jobs
Regulatory & Compliance HHS Undergoes Massive Restructuring, Slashing 10,000 Jobs

The U.S. Department of Health and Human Services (HHS) unveiled a massive restructuring plan early one morning, announcing the elimination of 10,000 full-time employees, reducing its number of divisions from 28 to 15, and halving the number of regional offices. This extensive overhaul is intended

How Will HHS Layoffs and Reorganization Impact U.S. Healthcare?
Regulatory & Compliance How Will HHS Layoffs and Reorganization Impact U.S. Healthcare?

The Department of Health and Human Services (HHS) employees faced significant turmoil following the Trump administration's unexpected announcement of massive layoffs and restructuring. The HHS plans to terminate 10,000 full-time employees, reduce 28 divisions to 15, and halve the number of

Will Medicaid Cuts Harm Vulnerable Americans and Hit State Economies?
Regulatory & Compliance Will Medicaid Cuts Harm Vulnerable Americans and Hit State Economies?

The discussion surrounding potential Medicaid funding cuts has sparked vigorous debate, with hundreds of advocacy groups urging Senate Majority Leader John Thune to reconsider the proposed reductions. The implications of these cuts extend far beyond budgetary concerns, impacting millions of

Is Insourcing the Future of Pharmacy Benefit Management?
Digital Health Is Insourcing the Future of Pharmacy Benefit Management?

The landscape of Pharmacy Benefit Managers (PBMs) is undergoing a significant transformation. For decades, the three largest PBMs have dominated the market, but dissatisfaction with their rigidity, lack of transparency, and misaligned incentives is pushing many organizations to explore alternative

How Will New Zealand's SDHR Project Transform Healthcare Access?
Digital Health How Will New Zealand's SDHR Project Transform Healthcare Access?

Te Whatu Ora Health New Zealand has undertaken the Shared Digital Health Records (SDHR) project to consolidate patient health information for clinicians across the country. With funding of NZ$4 million, the project is set to launch its initial phase mid-year, aiming to streamline data from existing

AI Revolution: Medtech Giants Forge Ahead With Nvidia and Google Cloud
Digital Health AI Revolution: Medtech Giants Forge Ahead With Nvidia and Google Cloud

The medtech industry has undergone a significant transformation, with artificial intelligence (AI) driving unprecedented advancements and innovations. At Nvidia's annual artificial intelligence developer conference, GTC, leading medtech giants showcased their latest AI-driven projects,

Hospices Face Regulatory Challenges in 2025: Telehealth and Fraud
Digital Health Hospices Face Regulatory Challenges in 2025: Telehealth and Fraud

Hospice care providers are navigating an increasingly complex regulatory landscape, with telehealth policies and widespread fraud emerging as primary concerns. Insights from a recent survey involving 112 hospice professionals illuminate the pressing issues anticipated to impact the industry

What Drives Nuclear Medicine Market Growth and Future Projections?
Imaging & Diagnostics What Drives Nuclear Medicine Market Growth and Future Projections?

The nuclear medicine and radiopharmaceuticals market is on a trajectory to remarkable growth, with projections reaching USD 11.05 billion by 2030. Such significant expansion underscores the transformative impact of advancements in healthcare and diagnostic technologies, particularly in the realms

Are Human Challenge Studies Key to Advancing Covid-19 Research in Singapore?
Imaging & Diagnostics Are Human Challenge Studies Key to Advancing Covid-19 Research in Singapore?

Singapore is pioneering an innovative approach to Covid-19 research through human challenge studies, where volunteers are deliberately infected with the virus in controlled settings. This approach contrasts with traditional methods where infections occur naturally, allowing researchers to obtain

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later